Loading clinical trials...

Vital Pulp Therapy of Mature Permanent Teeth With Irreversible Pulpitis Using Bioceramic Material | Clinical Trials | Clareo Health

COMPLETEDNA

Vital Pulp Therapy of Mature Permanent Teeth With Irreversible Pulpitis Using Bioceramic Material

The Effect of Two Different Contemporary Chelating Agents on Vital Pulp Therapy in Mature Permanent Teeth With Irreversible Pulpitis Using Bioceramic Material

NCT05970536•Sinai University

View on ClinicalTrials.gov

Summary

This clinical trial is designed to study and compare the effect of two different types of chelating agents on the vital pulp therapy of mature permanent teeth with irreversible pulpitis using bioceramic material.

Detailed Description

1. The vital pulps exposed by caries process is treated by complete caries removal followed by full pulpotomy. 2. After hemostasis, application of apple vinegar and EDTA 17% will be used followed by MTA application. finally teeth will be restored with resin composite restoration.

Eligibility

Age

18 - 50 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Presence of at least one tooth with carious pulp exposure and irreversible pulpitis.
•Cooperative behavior with no medical problem.
•Absence of tooth mobility , tenderness on percussion.
•History of pain with cold and sweets.
•Radiographically, no internal or external resorption, no periapical or furcation radiolucency and no widening of the periodontal membrane space.

Exclusion Criteria

•Teeth with pulp necrosis.
•Presence of sinus tract.
•Teeth with open apices.
•Pregnant women.
•History of intolerance of non- steroidal anti inflammatory drugs.
•Tenderness to palpation of adjacent soft tissues

Locations (1)

Mona Rizk Abo El Wafa Ahmed

Cairo, Egypt

Key Dates

Start Date

December 1, 2022

Primary Completion Date

December 1, 2023

Completion Date

December 1, 2023

Last Updated

April 18, 2024

Enrollment

ACTUAL participants

Conditions

Vital Pulp Therapy

Interventions

Apple vinegar or EDTA 17%

OTHER

Comparative Evaluation of Melatonin Versus MTA on Vital Pulp Therapy in Young Permanent First Molars: An in Vivo Study

NCT06372561

Dental Caries in ChildrenVital Pulp Therapy

View study

COMPLETEDNA

Diagnostic Validity of a Quantitative Pulp Pain Scoring System and Its Association With Postoperative Clinical Outcomes

NCT07349511

Postoperative Pain After Endodontic TreatmentDirect Pulp Capping+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 18, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Vital Pulp Therapy of Mature Permanent Teeth With Irreversible Pulpitis Using Bioceramic Material

Inclusion Criteria

Exclusion Criteria

Comparative Evaluation of Melatonin Versus MTA on Vital Pulp Therapy in Young Permanent First Molars: An in Vivo Study

Diagnostic Validity of a Quantitative Pulp Pain Scoring System and Its Association With Postoperative Clinical Outcomes

Knowledge of Vital Pulp Therapy in Permanent Teeth Among a Group of Dental Students in Egypt

Effect of Topical Dexamethasone on Histologic Response of Human Dental Pulp